Delivery Order SPE2DB22D3016-SPE2DB25FAVG9

Award Date 5/1/25
Potential Completion Date 5/22/25
Potential Value $5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $31,311.18 firm-fixed-price contract is for the supply of Opdivo, a 240 mg/24 mL cancer medication, with a period of performance through May 2025. The contract is not set aside and represents an order under AmerisourceBergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. This IDC serves as a comprehensive...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $9,937.86 and is for the supply of 240 mg/24 ml vials of the cancer medication Opdivo. The contract is not set aside and is a firm fixed-price delivery order with a performance period through May 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,257.68 firm fixed-price contract is for the supply of 100 mg/10 ml vials of the drug Opdivo, with a performance period ending on April 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Opdivo (nivolumab) 240 mg/24 mL vials. The contract has an ultimate completion date of May 6, 2025 and a ceiling value of $14,906.79. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Opdivo 240 mg/24 ml vials. The contract has a ceiling value of $26,342.25 and a period of performance through February 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $9,739.10, is for the delivery of Opdivo Qvantig 600 mg-10,000 5 ml, a medication used in the treatment of various medical conditions. The contract is a firm fixed-price delivery order and is not set aside for any special type of business. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of OPDIVO 100 MG/10 ML VIAL 10ML. The firm fixed-price contract has a ceiling value of $9,974.55 and runs through December 12, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as the primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $49,689.30, is for the supply of OPDIVO 240 MG/24 ML VIAL 24ML, a specialty medication. The contract is a firm fixed-price delivery order, with a completion date of March 25, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Opdivo (nivolumab) 240 mg/24 mL vials. The contract, which is not set aside, has a ceiling value of $38,237 and a completion date of October 17, 2024. Amerisourcebergen, through its extensive federal contracting experience and nationwide distribution network, will provide this critical oncology medication to support the healthcare needs of...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $78,951.60 firm fixed price Delivery Order is for the supply of Opdivo 240 mg/24 ml vials, a specialty medication used in the treatment of various cancers. The contract has an ultimate completion date of October 3, 2022 and is not designated as a set-aside. This award is part of a larger...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAVG9
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,968.93, is for the delivery of Opdivo 240 mg/24 ml vials, a medication used to treat various types of cancer.

The contract is not set aside and is a firm fixed-price delivery order with a performance period through May 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs through December 2026. This delivery order is likely part of the broader IDC, allowing the DLA to procure pharmaceutical products and medical supplies to support its healthcare operations.

Generated 7/31/25, 9:56 AM